AI Summary According to www.liverdirectory.com, the AFP blood test is a tumor marker that helps watch for liver cancer (HCC) in people at high risk, such as those with cirrhosis. Doctors pair it with a liver ultrasound about every six months. A level above 15 ng/mL raises suspicion, but AFP cannot diagnose cancer alone. A high result leads to contrast CT or MRI, sometimes a biopsy, and a team plans treatment if HCC is confirmed.
Source: www.liverdirectory.com
Medically Reviewed.
Alpha-fetoprotein (AFP) is measured with a blood test. In liver care, it is a tumor marker: a substance that can rise in the blood when hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is present.
Doctors pair an AFP test with a liver ultrasound about every six months for people with cirrhosis. A high result raises suspicion but does not diagnose cancer. Imaging, and sometimes a biopsy, confirm it.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
AFP BLOOD TEST BASICS
The AFP test measures alpha-fetoprotein in a sample of your blood. It is a routine blood draw. AFP is one of three tumor markers doctors use for liver cancer. The other two are AFP-L3 and des-gamma-carboxy prothrombin (DCP, also called PIVKA-II).
Doctors mainly use AFP to watch for HCC in people whose liver disease puts them at high risk. Early liver cancer often causes no symptoms, so testing on a schedule can find a problem before you feel it.
AFP is a clue, not a verdict. Doctors advise against using AFP alone to diagnose HCC, because it is not accurate enough. Your care team reads the number together with your imaging, your liver disease, and your symptoms.
LIVER CANCER SCREENING SCHEDULE
AFP testing is for people whose liver disease raises their risk of HCC. Your schedule depends on your condition.
Doctors advise HCC surveillance for everyone with Child-Turcotte-Pugh A or B cirrhosis, from any cause. The usual plan is an ultrasound combined with an AFP test every six months. About 1% to 8% of people with cirrhosis develop HCC each year, depending on the cause.
Doctors also advise surveillance for men age 40 and older and women older than 50 who have chronic hepatitis B without cirrhosis and come from regions where the virus is common.
For Child-Turcotte-Pugh C cirrhosis, surveillance is advised only when the person is a liver transplant candidate. It is not advised when the person is not eligible for transplant, or has another serious condition that limits life expectancy to less than one to two years.
A past HCC is a very high risk factor. Checks every four months are advised, with an abdominal ultrasound and tumor markers such as AFP, AFP-L3, or DCP.
Curing hepatitis C with direct-acting antivirals lowers risk but does not remove it, especially with cirrhosis. Ultrasound every six months is advised for the first two years, with tumor marker tests at the doctor's discretion. If nothing is found, checks may move to every 12 months, focused on ultrasound and AFP. An elevated AFP at the end of treatment is also a sign of higher risk.
Routine screening is not currently advised for people with metabolic fatty liver disease (MAFLD) who do not have cirrhosis, because their yearly risk is much lower. Ask your doctor whether cirrhosis has been ruled out.
LIVER CANCER TEST COMPARISON
No single test does every job. Each one plays a different part in finding and confirming HCC.
| Test | What it does | Role in HCC care |
|---|---|---|
| AFP blood test | Measures a tumor marker in your blood | Added to ultrasound for surveillance. Cannot diagnose cancer on its own. |
| Liver ultrasound | Uses sound waves to image the liver | The main surveillance scan, usually every six months. |
| Contrast CT or MRI | Shows how blood flows through a liver spot | Confirms HCC in people with cirrhosis or chronic hepatitis B when a spot has typical features (LI-RADS). |
| Liver biopsy | Takes a small tissue sample | Used when a nodule stays unclear after imaging, and for people outside high-risk groups. |
| AFP-L3 and DCP | Measure two other tumor markers | Markers other than AFP lack enough long-term data for routine screening. They are paired with AFP after a past HCC. |
AFP adds sensitivity for early-stage HCC when combined with ultrasound, but it lowers specificity. That trade-off is why doctors treat a high result as a reason to look closer.
UNDERSTANDING YOUR AFP LEVEL
Your lab report shows an AFP number. Labs set their own reference ranges, so read the result with your care team rather than on its own.
An AFP level above 15 ng/mL should significantly raise suspicion for cancer. Your lab report may use a different cutoff, so check the range printed on it.
A lower result does not rule out cancer. AFP adds sensitivity to ultrasound, but it does not catch every HCC, which is why the ultrasound stays part of every check.
An elevated AFP can prompt closer imaging or a biopsy, especially when a nodule is unclear on imaging. Your doctor may also track whether your AFP is rising over time, alongside your scans.
Because adding AFP lowers specificity, some high results do not mean cancer. That is why a high AFP leads to more tests, not a diagnosis.
An AFP result is one piece of information. Doctors weigh it with your imaging, your liver disease, and your symptoms.
AFP FOLLOW-UP PLAN
A high AFP is a signal to look closer. These are the steps doctors usually take.
A biopsy is needed when imaging stays unclear, and for people outside the high-risk groups.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
APPOINTMENT QUESTIONS
These questions can help you get the most from your next appointment.
Common Questions
No. A high AFP raises suspicion, but it does not diagnose liver cancer. AFP is a tumor marker, which means it is a clue that points doctors toward a closer look. Doctors advise against using AFP alone for diagnosis because it is not accurate enough on its own. To confirm hepatocellular carcinoma (HCC), your team uses imaging, usually a contrast-enhanced CT or MRI. If a spot on the liver stays unclear after imaging, a biopsy may follow. AFP can also be raised in some liver diseases that are not cancer, such as cirrhosis and hepatitis, so a high number alone does not tell your doctor what is going on.
Yes. A normal AFP does not rule out HCC. AFP adds sensitivity when it is combined with ultrasound, which means it helps find more early-stage cancers. But it does not catch every cancer, and some tumors do not raise AFP at all. That is why surveillance pairs the blood test with a liver ultrasound, usually about every six months in people with cirrhosis. Keep your scheduled ultrasounds even when your AFP result looks fine, and tell your doctor about any new symptoms between visits.
An AFP level above 15 ng/mL should significantly raise suspicion for cancer. Ng/mL stands for nanograms per milliliter, the unit most labs use to report AFP in blood. Labs set their own reference ranges, so your report may print a different cutoff. Use the range on your report and ask your doctor what your number means for you. Doctors also look at whether your AFP is rising over time, together with your scans, your liver disease, and your symptoms. A high result leads to more tests, not to a diagnosis.
No special preparation is listed for the AFP test. It is a routine blood draw, and the lab measures alpha-fetoprotein in a small sample of your blood. Instructions can differ between clinics and labs, especially if your doctor orders other blood tests at the same visit. Ask your clinic or lab whether they have any instructions for you before you go. It also helps to bring your last AFP result so your care team can compare the numbers.
Your doctor will look closer, and a high AFP does not mean you have cancer. First, your doctor reviews the result with your latest ultrasound and your liver disease history. You may then have a contrast-enhanced CT or MRI. In people with cirrhosis or chronic hepatitis B, HCC can be diagnosed from typical imaging features. If a nodule stays unclear, your team may repeat imaging at a set interval or take a biopsy. If HCC is confirmed, a multidisciplinary team plans treatment based on the tumor, your liver function, and your other health conditions. Keep your follow-up appointments and bring your questions.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
